Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Written consent for human immunodeficiency virus testing.

Myers JE, Henning KJ, Frieden TR, Larson K, Begier B, Sepkowitz KA.

Public Health Rep. 2007 Jul-Aug;122(4):433-4. No abstract available.

2.

Why don't physicians test for HIV? A review of the US literature.

Burke RC, Sepkowitz KA, Bernstein KT, Karpati AM, Myers JE, Tsoi BW, Begier EM.

AIDS. 2007 Jul 31;21(12):1617-24. Review.

PMID:
17630557
3.

Association between rates of HIV testing and elimination of written consents in San Francisco.

Zetola NM, Klausner JD, Haller B, Nassos P, Katz MH.

JAMA. 2007 Mar 14;297(10):1061-2. No abstract available.

PMID:
17356026
4.

Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.

Paltiel AD, Walensky RP, Schackman BR, Seage GR 3rd, Mercincavage LM, Weinstein MC, Freedberg KA.

Ann Intern Med. 2006 Dec 5;145(11):797-806.

PMID:
17146064
5.

Missed opportunities for earlier diagnosis of HIV infection--South Carolina, 1997-2005.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2006 Dec 1;55(47):1269-72.

6.

The lifetime cost of current human immunodeficiency virus care in the United States.

Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage GR 3rd, Moore RD, Freedberg KA.

Med Care. 2006 Nov;44(11):990-7. Review.

PMID:
17063130
7.

HIV screening in health care settings: public health and civil liberties in conflict?

Gostin LO.

JAMA. 2006 Oct 25;296(16):2023-5. No abstract available.

PMID:
17062866
8.

Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, Clark JE; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4.

9.

Changing the paradigm for HIV testing--the end of exceptionalism.

Bayer R, Fairchild AL.

N Engl J Med. 2006 Aug 17;355(7):647-9. No abstract available.

10.

Epidemiology of HIV/AIDS--United States, 1981-2005.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2006 Jun 2;55(21):589-92.

11.

Assessing the impact of federal HIV prevention spending on HIV testing and awareness.

Linas BP, Zheng H, Losina E, Walensky RP, Freedberg KA.

Am J Public Health. 2006 Jun;96(6):1038-43. Epub 2006 May 2.

12.

HIV counseling and testing: less targeting, more testing.

Koo DJ, Begier EM, Henn MH, Sepkowitz KA, Kellerman SE.

Am J Public Health. 2006 Jun;96(6):962-4. Epub 2006 May 2. No abstract available.

13.

Risk-based human immunodeficiency virus (HIV) testing fails to detect the majority of HIV-infected persons in medical care Settings.

Jenkins TC, Gardner EM, Thrun MW, Cohn DL, Burman WJ.

Sex Transm Dis. 2006 May;33(5):329-33.

PMID:
16547450
14.

Applying public health principles to the HIV epidemic.

Frieden TR, Das-Douglas M, Kellerman SE, Henning KJ.

N Engl J Med. 2005 Dec 1;353(22):2397-402. No abstract available.

15.

Trends in HIV/AIDS diagnoses--33 states, 2001-2004.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2005 Nov 18;54(45):1149-53.

16.
17.

Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

Paltiel AD, Weinstein MC, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, Freedberg KA, Walensky RP.

N Engl J Med. 2005 Feb 10;352(6):586-95.

18.

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK.

N Engl J Med. 2005 Feb 10;352(6):570-85.

20.

Assessing missed opportunities for HIV testing in medical settings.

Liddicoat RV, Horton NJ, Urban R, Maier E, Christiansen D, Samet JH.

J Gen Intern Med. 2004 Apr;19(4):349-56.

Supplemental Content

Support Center